Form 4: Evolent Health Director Acquires Shares

Evolent Health Director Peter J. Grua acquired 41,096 shares of Class A Common Stock through restricted stock units, increasing his beneficial ownership.

Summary

• Peter J. Grua, a Director at Evolent Health, Inc., acquired 41,096 shares of Class A Common Stock on June 4, 2026.
• These shares were granted as restricted stock units (RSUs) under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• The securities vest on June 4, 2027, or the date of the Company's 2027 annual meeting, contingent on Grua's continued service.
• Following this transaction, Grua beneficially owns 63,075 shares of Class A Common Stock, with 60,668 held indirectly through the Peter J. Grua 2004 Revocable Trust.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard grant and acquisition of equity by a director, indicating continued commitment rather than a significant new development.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 41,096 shares increases the reporting person's stake in the company.

Risks

• Vesting of securities is subject to the reporting person's continued service, implying a risk of forfeiture if service is terminated before the vesting date.

Future Outlook

The restricted stock units are set to vest on June 4, 2027, or the date of the Company's 2027 annual meeting, provided Mr. Grua continues his service.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of restricted stock units by a director, are common disclosures in the healthcare technology sector and can provide insights into management's perception of company value.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares positively, as it aligns management's interests with those of other shareholders.
• Employees may see this as a sign of confidence from leadership, potentially impacting morale.

Next Steps

• Vesting of 41,096 restricted stock units on or before June 4, 2027, contingent on continued service.

Key Dates

Keywords

Evolent Health, EVH, Form 4, Insider Trading, Restricted Stock Units, Director, Class A Common Stock, Beneficial Ownership, SEC Filing